BAYLOR COLLEGE OF MEDICINE
Inflammatory caspase activation in sickle cell disease
Inflammatory caspase activation in sickle cell disease is a funding opportunity from BAYLOR COLLEGE OF MEDICINE, up to 689292, closing March 31, 2028.
Mar 31, 2028
(609d left)Overview
SUMMARY New, inexpensive, accessible treatments are urgently needed to regulate chronic inflammation in sickle cell dis- ease (SCD). SCD is a devastating red blood cell disorder that impacts millions of people worldwide. The majority of clinical symptoms in SCD, including stroke, vaso-occclusive crisis (VOC), and…